Psychemedics Corp.
(NASDAQ : PMD)

( )
PMD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Servicestothe Health Industry
symbolcompany%chnglast%shortavg$volume
IQVIQVIA Holdings, Inc. 2.24%162.880.0%$175.27m
DGXQuest Diagnostics, Inc. 0.80%121.104.3%$161.16m
LHLaboratory Corp. of America Holdings 1.06%188.102.4%$144.30m
SYNHSyneos Health, Inc. 2.26%63.920.0%$31.72m
IDXGInterpace Biosciences, Inc. -2.37%6.1722.8%$2.80m
NRCNational Research Corp. -2.42%57.200.0%$1.86m
AMEHApollo Medical Holdings, Inc. 2.10%18.000.0%$0.97m
PLXProtalix Biotherapeutics, Inc. -0.55%3.6526.0%$0.92m
BASIBioanalytical Systems, Inc. -1.15%5.600.2%$0.21m
PMDPsychemedics Corp. 0.20%5.140.7%$0.16m

Company Profile

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.